Article Text

Download PDFPDF
CT-diagnosed emphysema and lung cancer mortality: novel association or old news?
  1. Jennifer K Quint
  1. Correspondence to Dr Jennifer K Quint, Respiratory Epidemiology, Occupational Medicine and Public Health, National Heart and Lung Institute, Emmanuel Kaye Building, Imperial College London, London SW3 6LR, UK; j.quint{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Hippocrates may well have appreciated the significance of the presence of emphysema, but it was not until the 17th century that Bonet1 described the larger lungs of those with emphysema, to which he attributed their breathlessness. In 1821, Laennec connected emphysema to ageing, when he ascribed a subtly different definition to emphysema, describing it as “a breakdown of tissue in the parenchyma of the lungs as opposed to air trapped in the alveoli due to obstruction as occurs in asthma and chronic bronchitis” essentially considering emphysema to be an ‘independent finding’ to obstructive lung disease, although at postmortem.2 Fast forward 200 years, and one could argue that even in 2016 the significance of emphysema on a CT scan in someone who does not have airflow obstruction or clinical symptoms of breathlessness is unclear.

Even the significance of emphysema among people with COPD and the association between emphysema and smoking are obscure. Around half of patients with COPD do not have significant emphysema,3 and up to 10% of never smokers have evidence of emphysema at postmortem.4 On the …

View Full Text


  • Competing interests JKQ reports grants from MRC, grants from GSK, personal fees from AZ, grants from BLF, outside the submitted work.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles